Use of comprehensive genomic profiling for biomarker discovery for the management of non-small cell lung cancer brain metastases

Use of comprehensive genomic profiling for biomarker discovery for the management of non-small cell lung cancer brain metastases

BackgroundClinical biomarkers for brain metastases remain elusive. Increased availability of genomic profiling has brought discovery of these biomarkers to the forefront of research interests.MethodIn this single institution retrospective series, 130 patients presenting with brain metastasis seconda...

Full description

Bibliographic Details
Main Authors: Mohammed Abdulhaleem, John C. Hunting, Yuezhu Wang, Margaret R. Smith, Ralph D’ jr. Agostino, Thomas Lycan, Michael K. Farris, James Ververs, Hui-Wen Lo, Kounosuke Watabe, Umit Topaloglu, Wencheng Li, Christopher Whitlow, Jing Su, Ge Wang, Michael D. Chan, Fei Xing, Jimmy Ruiz
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-11-01
Series:Frontiers in Oncology
Subjects:
brain metastasis
non-small cell lung cancer
outcomes
biomarkers
genomic profiling
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1214126/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1214126/full

Similar Items